The power of precision
For every cancer patient
Today

Latest news
Improved communication from 2cureX AB
Read more

Press releases & news

  • Improved communication from 2cureX AB

    Read more
  • Correction: CEO Nathaniel Hutley presents latest news from 2cureX on July 2nd 2025.

    Read more
  • 2cureX AB is in the process of securing a strategic collaboration with PreComb Therapeutics AG.

    Read more
  • KOMMUNIKÉ FRÅN ÅRSSTÄMMAN I 2CUREX AB (PUBL)

    Read more
All press realeases & news

Latest report

Latest presentation

  • 2CUREX PRESENTS AT REDEYE FIGHT CANCER

Calendar & upcoming events

All events

Information for Oncologists and Pathologists

Know more when it matters most:
With our IndiTreat® tests you can finally obtain personalised information, even on the classic compounds for the main chemotherapy backbone for your stage IV mCRC patients.

More

Information for Patients

You’ve been diagnosed with colorectal cancer, and it is in stage IV. There are rational treatment choices to be made. Which therapy is more likely to impact the tumor? Ask your doctor about IndiTreat®.

More